• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gender differences and daily variation in atrial fibrillation risk factor profiles: Considerations for risk factor management.

作者信息

Pluymaekers Nikki A H A, Hermans Astrid N L, Middeldorp Melissa E, Kadhim Kadhim, Crijns Harry J G M, Sanders Prashanthan, Linz Dominik

机构信息

Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, the Netherlands.

Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.

出版信息

Int J Cardiol Heart Vasc. 2019 Nov 19;25:100442. doi: 10.1016/j.ijcha.2019.100442. eCollection 2019 Dec.

DOI:10.1016/j.ijcha.2019.100442
PMID:31890862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6923505/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b0/6923505/3d0f41cedfbb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b0/6923505/3d0f41cedfbb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b0/6923505/3d0f41cedfbb/gr1.jpg

相似文献

1
Gender differences and daily variation in atrial fibrillation risk factor profiles: Considerations for risk factor management.心房颤动危险因素特征的性别差异及每日变化：危险因素管理的考量
Int J Cardiol Heart Vasc. 2019 Nov 19;25:100442. doi: 10.1016/j.ijcha.2019.100442. eCollection 2019 Dec.
2
Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes.心房颤动中的性别差异：流行病学、管理及结局综述
Curr Cardiol Rev. 2019;15(2):136-144. doi: 10.2174/1573403X15666181205110624.
3
Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY).女性与男性慢性心房颤动患者的对比：来自标准与心房颤动特定管理研究（SAFETY）的见解。
PLoS One. 2013 May 29;8(5):e65795. doi: 10.1371/journal.pone.0065795. Print 2013.
4
Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.伴有单一卒中危险因素的房颤患者中标准剂量非维生素 K 拮抗剂口服抗凝剂和华法林的有效性和安全性：一项全国性队列研究。
JAMA Cardiol. 2017 Aug 1;2(8):872-881. doi: 10.1001/jamacardio.2017.1883.
5
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program.新发心房颤动抗栓治疗的性别差异：GLORIA-AF 登记研究。
Am J Med. 2018 Aug;131(8):945-955.e3. doi: 10.1016/j.amjmed.2018.03.024. Epub 2018 Apr 11.
6
Sex-Related Differences in Catheter Ablation for Patients With Atrial Fibrillation and Heart Failure.心房颤动合并心力衰竭患者导管消融治疗中的性别差异
Front Cardiovasc Med. 2020 Dec 14;7:614031. doi: 10.3389/fcvm.2020.614031. eCollection 2020.
7
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response.性别差异与心房颤动：从血栓栓塞风险到抗凝治疗反应。
Medicina (Kaunas). 2023 Jan 28;59(2):254. doi: 10.3390/medicina59020254.
8
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.加拿大心血管学会 2012 年心房颤动指南重点更新：卒中预防和节律/心率控制推荐。
Can J Cardiol. 2012 Mar-Apr;28(2):125-36. doi: 10.1016/j.cjca.2012.01.021.
9
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).非瓣膜性心房颤动患者中利伐沙班与华法林临时中断治疗的结局：每日口服一次、直接 Xa 因子抑制剂利伐沙班与维生素 K 拮抗剂预防心房颤动血栓栓塞（ROCKET AF）研究。
Circulation. 2014 May 6;129(18):1850-9. doi: 10.1161/CIRCULATIONAHA.113.005754. Epub 2014 Feb 19.
10
Physician variation in the management of patients with atrial fibrillation.心房颤动患者管理中的医生差异。
Heart. 1996 Feb;75(2):200-5. doi: 10.1136/hrt.75.2.200.

引用本文的文献

1
Fear of Recurrence of Atrial Fibrillation: Translating a Cancer Fear Model to the Atrial Fibrillation Patient Experience.对心房颤动复发的恐惧：将癌症恐惧模型应用于心房颤动患者体验
Front Psychiatry. 2022 Jul 4;13:915327. doi: 10.3389/fpsyt.2022.915327. eCollection 2022.
2
Sleep apnea and atrial fibrillation: Update 2020.睡眠呼吸暂停与心房颤动：2020年最新进展
Int J Cardiol Heart Vasc. 2020 Nov 27;31:100681. doi: 10.1016/j.ijcha.2020.100681. eCollection 2020 Dec.
3
On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation.

本文引用的文献

1
Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome.早发性心房颤动：临床特征、进展率和心血管结局的性别差异。
Int J Cardiol Heart Vasc. 2019 Nov 7;25:100429. doi: 10.1016/j.ijcha.2019.100429. eCollection 2019 Dec.
2
Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring.心房颤动患者夜间睡眠呼吸暂停严重程度：长期睡眠呼吸暂停监测的潜在应用
Int J Cardiol Heart Vasc. 2019 Oct 18;24:100424. doi: 10.1016/j.ijcha.2019.100424. eCollection 2019 Sep.
3
Self-Reported Daytime Sleepiness and Sleep-Disordered Breathing in Patients With Atrial Fibrillation: SNOozE-AF.
按需移动健康基础设施，通过远程会诊实现全面的远程房颤及风险因素管理。
Clin Cardiol. 2020 Nov;43(11):1232-1239. doi: 10.1002/clc.23469. Epub 2020 Oct 8.
房颤患者的日间嗜睡和睡眠呼吸障碍的自我报告：SNOozE-AF。
Can J Cardiol. 2019 Nov;35(11):1457-1464. doi: 10.1016/j.cjca.2019.07.627. Epub 2019 Aug 1.
4
Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population.血压、血糖水平、总胆固醇水平和体重指数的变异性对健康人群心房颤动风险的影响。
Heart Rhythm. 2020 Jan;17(1):12-19. doi: 10.1016/j.hrthm.2019.07.006. Epub 2019 Jul 9.
5
Variability of Sleep Apnea Severity and Risk of Atrial Fibrillation: The VARIOSA-AF Study.睡眠呼吸暂停严重程度的变异性与心房颤动风险：VARIOSA-AF 研究。
JACC Clin Electrophysiol. 2019 Jun;5(6):692-701. doi: 10.1016/j.jacep.2019.03.005. Epub 2019 May 1.
6
Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk.睡眠呼吸暂停严重程度的夜间变化与心房颤动风险
J Am Coll Cardiol. 2018 Nov 6;72(19):2406-2407. doi: 10.1016/j.jacc.2018.08.2159.
7
Efficacy of temperature-guided cryoballoon ablation without using real-time recordings - 12-Month follow-up.不使用实时记录的温度引导冷冻球囊消融术的疗效——12个月随访
Int J Cardiol Heart Vasc. 2018 Oct 4;21:50-55. doi: 10.1016/j.ijcha.2018.09.009. eCollection 2018 Dec.
8
Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging.用于心房颤动的抗心律失常药物：即将出现新的进展。
Int J Cardiol Heart Vasc. 2018 Sep 13;21:11-15. doi: 10.1016/j.ijcha.2018.08.005. eCollection 2018 Dec.
9
The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia.性别对心房颤动发生率和向痴呆进展的影响。
Am J Cardiol. 2018 Nov 1;122(9):1489-1495. doi: 10.1016/j.amjcard.2018.07.031. Epub 2018 Aug 3.
10
Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios.口服抗凝药在具有复杂情况的心房颤动患者中用于预防卒中。
Int J Cardiol Heart Vasc. 2018 Aug 31;20:56-62. doi: 10.1016/j.ijcha.2018.08.003. eCollection 2018 Sep.